Joseph Press

Insider Reports History

Location
Tel Aviv Jaffa, Israel
Signature
/s/ Joseph Press
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph Press:

Company Role Class Num Shares Value Price $ Report Date Ownership
Raphael Pharmaceutical Inc. Director Common Stock 280,000 $140,000 $0.5000 26 Jul 2022 Direct
Raphael Pharmaceutical Inc. Director Warrants to Purchase Common Stock 105,000 05 Dec 2022 Direct

Insider Reports Filed by Joseph Press

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPH Raphael Pharmaceutical Inc. 26 Jul 2022 2 $0 4 Director 13 Mar 2023, 16:02
NONE Raphael Pharmaceutical Inc. 27 Sep 2021 0 $0 3 Director 19 Jan 2022, 10:01